Palladium-Catalyzed C–H Functionalization Using Guanidine as a Directing Group: Ortho Arylation and Olefination of Arylguanidines

Palladium-catalyzed C–H functionalization using guanidine as the directing group was achieved under mild reaction conditions. Various guanidine derivatives were produced in moderate to good yields by using simple unactivated arenes or ethyl acrylate as the source of arylation or olefination, respectively

Potent μ‑Opioid Receptor Agonists from Cyclic Peptides Tyr‑<i>c</i>[d‑Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation

To optimize the structure of a μ-opioid receptor ligand, analogs H-Tyr-<i>c</i>[d-Lys-Xxx-Tyr-Gly] were synthesized and their biological activity was tested. The analog containing a Phe³ was identified as not only exhibiting binding affinity 14-fold higher than the original hit but also producing agonist activity 3-fold more potent than morphine. NMR study suggested that a trans conformation at d-Lys²-Xxx³ is crucial for these cyclic peptides to maintain high affinity, selectivity, and functional activity toward the μ-opioid receptor

Potent μ‑Opioid Receptor Agonists from Cyclic Peptides Tyr‑<i>c</i>[d‑Lys-Xxx-Tyr-Gly]: Synthesis, Biological, and Structural Evaluation

To optimize the structure of a μ-opioid receptor ligand, analogs H-Tyr-<i>c</i>[d-Lys-Xxx-Tyr-Gly] were synthesized and their biological activity was tested. The analog containing a Phe³ was identified as not only exhibiting binding affinity 14-fold higher than the original hit but also producing agonist activity 3-fold more potent than morphine. NMR study suggested that a trans conformation at d-Lys²-Xxx³ is crucial for these cyclic peptides to maintain high affinity, selectivity, and functional activity toward the μ-opioid receptor

Distribution of molecular weights for 115 compounds docked utilizing both FRED and GlideXP.

<p>These are the top 115 scoring compounds obtained from docking the Maybridge database to the mouse PC2 models. The compounds are color-coded based on molecular weight. Yellow is the median and represents a molecular weight of 283.31 Da.</p

Identification of a Small Molecule That Selectively Inhibits Mouse PC2 over Mouse PC1/3: A Computational and Experimental Study

<div><p>The calcium-dependent serine endoproteases prohormone convertase 1/3 (PC1/3) and prohormone convertase 2 (PC2) play important roles in the homeostatic regulation of blood glucose levels, hence implicated in diabetes mellitus. Specifically, the absence of PC2 has been associated with chronic hypoglycemia. Since there is a reasonably good conservation of the catalytic domain between species translation of inhibitory effects is likely. In fact, similar results have been found using both mouse and human recombinant enzymes. Here, we employed computational structure-based approaches to screen 14,400 compounds from the Maybridge small molecule library towards mouse PC2. Our most remarkable finding was the identification of a potent and selective PC2 inhibitor. Kinetic data showed the compound to be an allosteric inhibitor. The compound identified is one of the few reported selective, small-molecule inhibitors of PC2. In addition, this new PC2 inhibitor is structurally different and of smaller size than those reported previously. This is advantageous for future studies where structural analogues can be built upon.</p> </div

Maybridge Compound Screening of PC1/3 and PC2.

<p>Negative numbers represent stimulation.</p><p>% error is shown in parenthesis.</p><p>Bold represent compounds with relevant inhibition or stimulation effect towards either PC.</p

The active site and potential allosteric sites of PC2, as determined using two structural models of the enzyme.

<p>The first and second numbers in parentheses denote the ranking of each site in model 6 and the homology model, respectively. (See the section <i>Generating structural models of PC2 for ligand docking</i> for details).</p

Enzymatic assay of RJC00847 against PC2.

<p><b>A</b>). The effect of increasing the concentration of the inhibitor on the detection of fluorescent product, 7-amino-4-methylcoumarin (AMC). <b>B</b>). Concentration-response curve, from which an IC₅₀ value of 1.1±0.06 µM was determined.</p

Selected peptides and small molecules active towards PC2.

<p>Selected peptides and small molecules active towards PC2.</p

Compounds that activated PC2 (HTS05737 and JFD02062) and PC1/3 (BTB03195).

<p>RJC00847 selectively inhibited PC2.</p